相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness
Isabel C. Lopez-Mejia et al.
MOLECULAR ONCOLOGY (2023)
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations
Priscilla K. Brastianos et al.
JOURNAL OF CLINICAL ONCOLOGY (2023)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Connexin 43 confers chemoresistance through activating PI3K
Kevin J. Pridham et al.
ONCOGENESIS (2022)
Deubiquitinating enzyme USP9X regulates metastasis and chemoresistance in triple-negative breast cancer by stabilizing Snail1
Tangming Guan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2022)
Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
Beilei Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Emerging therapeutic opportunities for integrin inhibitors
R. J. Slack et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Targeting of the alphav beta3 integrin complex by CAR-T cells leads to rapid regression of diffuse intrinsic pontine glioma and glioblastoma
Dustin A. Cobb et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment
Ewa Brzozowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Blockade of integrin signaling reduces chemotherapy-induced premature senescence in collagen cultured bladder cancer cells
Linghui Deng et al.
PRECISION CLINICAL MEDICINE (2022)
Alpelisib Monotherapy for PI3K-Altered Pretreated Advanced Breast Cancer A Phase II Study
Peter Savas et al.
CANCER DISCOVERY (2022)
Integrin-mediated cancer progression as a specific target in clinical therapy
Jian-Rui Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
3D matrix promotes cell dedifferentiation into colorectal cancer stem cells via integrin/cytoskeleton/glycolysis signaling
Tong Han et al.
CANCER SCIENCE (2022)
Integrin regulation by tissue factor promotes cancer stemness and metastatic dissemination in breast cancer
Betul Unlu et al.
ONCOGENE (2022)
MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/beta-catenin pathway
Te-Hsuan Jang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2022)
Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer
Archis Bagati et al.
CANCER CELL (2021)
Integrin α2β1 inhibition attenuates prostate cancer cell proliferation by cell cycle arrest, promoting apoptosis and reducing epithelial-mesenchymal transition
Zahra Salemi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells
Yu Shi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells
Romana Dolinschek et al.
MOLECULAR ONCOLOGY (2021)
Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age?
Jiajie Hou et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
Francesco Pantano et al.
ONCOGENE (2021)
Milk fat globule EGF factor 8 restores mitochondrial function via integrin-medicated activation of the FAK-STAT3 signaling pathway in acute pancreatitis
Yifan Ren et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Integrin Regulation in Immunological and Cancerous Cells and Exosomes
Zay Yar Soe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma
T. Y. S. Le Large et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways
Xi Zhang et al.
CELL DEATH & DISEASE (2021)
Regulatory T cells promote cancer immune-escape through integrin αvβ8-mediated TGF-β activation
Alexandra Laine et al.
NATURE COMMUNICATIONS (2021)
The Multifaceted Roles of EGFL7 in Cancer and Drug Resistance
Beate Heissig et al.
CANCERS (2021)
Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma Cells
Pulin Che et al.
CANCERS (2021)
Discovery of antiproliferative and anti-FAK inhibitory activity of 1,2,4-triazole derivatives containing acetamido carboxylic acid skeleton
Muhamad Mustafa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Efficacy and safety of bosutinib versus imatinib for newly diagnosed chronic myeloid leukemia in the Asian subpopulation of the phase 3 BFORE trial
Charles Chuah et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)
New Thyrointegrin αvβ3 Antagonist with a Scalable Synthesis, Brain Penetration, and Potent Activity against Glioblastoma Multiforme
Bruce A. Hay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
Matthew J. Matasar et al.
LANCET ONCOLOGY (2021)
Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma
Fangfang Liu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Exosomal integrins and their influence on pancreatic cancer progression and metastasis
Ilaria Casari et al.
CANCER LETTERS (2021)
Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance
Celia Cintas et al.
MOLECULAR CANCER THERAPEUTICS (2021)
A Potential Role for Integrin-Linked Kinase in Colorectal Cancer Growth and Progression via Regulating Senescence and Immunity
Saleh Almasabi et al.
FRONTIERS IN GENETICS (2021)
A Phase I Trial of Dasatinib and Osimertinib in TKI Naive Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
Chul Kim et al.
FRONTIERS IN ONCOLOGY (2021)
Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF-beta and AKT/mTOR signaling pathways
Li Shijie et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Protective function of interleukin-22 in pulmonary fibrosis
Peiyu Gu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
Rebalancing TGF-β/Smad7 signaling via Compound kushen injection in hepatic stellate cells protects against liver fibrosis and hepatocarcinogenesis
Yang Yang et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2021)
MYC protein interactors in gene transcription and cancer
Corey Lourenco et al.
NATURE REVIEWS CANCER (2021)
Targeting TGFβ signal transduction for cancer therapy
Sijia Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Secretory Mucin SAC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Sternness
Koelina Ganguly et al.
CANCER RESEARCH (2021)
Lactate modulation of immune responses in inflammatory versus tumour microenvironments
Michelangelo Certo et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion
Hong Jiang et al.
GUT (2020)
ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts
Jin Sol Sung et al.
ONCOGENE (2020)
Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein
Tao Yuan et al.
MOLECULAR ONCOLOGY (2020)
Interaction between laminin-5γ2 and integrin β1 promotes the tumor budding of colorectal cancer via the activation of Yes-associated proteins
Bijiao Zhou et al.
ONCOGENE (2020)
A novel biphenyl compound IMB-S7 ameliorates hepatic fibrosis in BDL rats by suppressing Sp1-mediated integrin αv expression
Na Zhang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis
Shasha Ruan et al.
CANCER RESEARCH (2020)
Integrin Signaling in Glioma Pathogenesis: From Biology to Therapy
Aleksandra Ellert-Miklaszewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer
David E. Gerber et al.
LUNG CANCER (2020)
Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis
Alexandra Desnoyers et al.
MOLECULAR DIAGNOSIS & THERAPY (2020)
Controlling Immunity and Inflammation through Integrin-Dependent Regulation of TGF-β
Martijn Nolte et al.
TRENDS IN CELL BIOLOGY (2020)
Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer
H. S. Rugo et al.
ANNALS OF ONCOLOGY (2020)
T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
Marta Canel et al.
ELIFE (2020)
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
Paolo Ghia et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Extracellular Vesicles from Cancer-Associated Fibroblasts Containing Annexin A6 Induces FAK-YAP Activation by Stabilizing β1 Integrin, Enhancing Drug Resistance
Tomoyuki Uchihara et al.
CANCER RESEARCH (2020)
Dual Targeting of Norepinephrine Transporter (NET) Function and Thyrointegrin ανβ3 Receptors in the Treatment of Neuroblastoma
Ozlem Ozen Karakus et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Upregulated expression and function of theα4β1 integrin in multiple myeloma cells resistant to bortezomib
Silvia Sevilla-Movilla et al.
JOURNAL OF PATHOLOGY (2020)
Metabolic reprogramming sustains cancer cell survival following extracellular matrix detachment
Hitoshi Endo et al.
REDOX BIOLOGY (2020)
EDIL3 promotes epithelial-mesenchymal transition and paclitaxel resistance through its interaction with integrin αVβ3in cancer cells
J. Gasca et al.
CELL DEATH DISCOVERY (2020)
The Roles of Integrin α5β1 in Human Cancer
Jianbing Hou et al.
ONCOTARGETS AND THERAPY (2020)
Pregnancy-specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF-β/Smad signaling to drive breast cancer progression
Ying-Ying Liu et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
TGF-β signaling in liver metastasis
Dieuwke L. Marvin et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2020)
Exosome-derived ENO1 regulates integrin α6β4 expression and promotes hepatocellular carcinoma growth and metastasis
Keqiu Jiang et al.
CELL DEATH & DISEASE (2020)
Integrin αvβ8 serves as a Novel Marker of Poor Prognosis in Colon Carcinoma and Regulates Cell Invasiveness through the Activation of TGF-β1
Mingliang Zhou et al.
JOURNAL OF CANCER (2020)
Integrin α6β4-Src-AKT signaling induces cellular senescence by counteracting apoptosis in irradiated tumor cells and tissues
Seung Hee Jung et al.
CELL DEATH AND DIFFERENTIATION (2019)
A Transforming Growth Factor-β and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis
Jinqiang Zhang et al.
HEPATOLOGY (2019)
AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells
Petreena S. Campbell et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Prostate cancer sheds the αvβ3 integrin in vivo through exosomes
Shiv Ram Krishn et al.
MATRIX BIOLOGY (2019)
Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer
Nithikoon Aksorn et al.
ANTICANCER RESEARCH (2019)
Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling
Siyang Wen et al.
CANCER LETTERS (2019)
Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin β1
Gaoxiang Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
68Ga-DOTA-E[c(RGDfK)]2 PET Imaging of SHARPIN-Regulated Integrin Activity in Mice
Riikka Siitonen et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
Panagiotis A. Konstantinopoulos et al.
LANCET ONCOLOGY (2019)
Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies
Maja J. A. de Jonge et al.
TARGETED ONCOLOGY (2019)
NFAT1 Hypermethylation Promotes Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Carcinoma by Activating ITGA6 Transcription
Jian Zhang et al.
NEOPLASIA (2019)
Transforming Growth Factor-β Signaling in Immunity and Cancer
Eduard Batlle et al.
IMMUNITY (2019)
Integrin α9 depletion promotes β-catenin degradation to suppress triple-negative breast cancer tumor growth and metastasis
Zhishan Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study
Dean A. Fennell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival
Matilda Munksgaard Thoren et al.
CANCERS (2019)
LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
Cedric Zeltz et al.
CANCERS (2019)
Potential Role of Exosomes in Cancer Metastasis
Wenjuan Tian et al.
BIOMED RESEARCH INTERNATIONAL (2019)
α11β1 Integrin is Induced in a Subset of Cancer-Associated Fibroblasts in Desmoplastic Tumor Stroma and Mediates In Vitro Cell Migration
Cedric Zeltz et al.
CANCERS (2019)
Alphavbeta3 integrin blocking inhibits apoptosis and induces autophagy in murine breast tumor cells
Rafael Luis Bressani Lino et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Stromal integrin α11 regulates PDGFRβ signaling and promotes breast cancer progression
Irina Primac et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Acquired Resistance to EGFR TKIs Mediated by TGFβ1/Integrin β3 Signaling in EGFR-Mutant Lung Cancer
Caiyun Wang et al.
MOLECULAR CANCER THERAPEUTICS (2019)
被撤回的出版物: A DNA Nanodevice Simultaneously Activating the EGFR and Integrin for Enhancing Cytoskeletal Activity and Cancer Cell Treatment (Retracted article. See vol. 22, pg. 3175, 2022)
Mirza Muhammad Faran Ashraf Baig et al.
NANO LETTERS (2019)
αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion
Andrea Vannini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity
Xiaohang Long et al.
NATURE MICROBIOLOGY (2019)
Arl13b Regulates Breast Cancer Cell Migration and Invasion by Controlling Integrin-Mediated Signaling
Cristina Casalou et al.
CANCERS (2019)
Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma
Fengkai Sun et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Mariya Lazarova et al.
FRONTIERS IN IMMUNOLOGY (2019)
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
Shaoqiang Cheng et al.
CANCER BIOLOGY & THERAPY (2019)
A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines
L. Zhang et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2019)
Reciprocal regulation of integrin 4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits
Binbin Ma et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma
Y. Liu et al.
ONCOGENE (2019)
The Interaction between Laminin-332 and alpha 3 beta 1 Integrin Determines Differentiation and Maintenance of CAFs, and Supports Invasion of Pancreatic Duct Adenocarcinoma Cells
Ana C. Martins Cavaco et al.
CANCERS (2019)
Basis of PD1/PD-L1 Therapies
Barbara Seliger
JOURNAL OF CLINICAL MEDICINE (2019)
Extracellular matrix protein 1 promotes cell metastasis and glucose metabolism by inducing integrin β4/FAK/SOX2/HIF-1α signaling pathway in gastric cancer
L. Gan et al.
ONCOGENE (2018)
A dual-targeting reconstituted high density lipoprotein leveraging the synergy of sorafenib and antimiRNA21 for enhanced hepatocellular carcinoma therapy
Min Li et al.
ACTA BIOMATERIALIA (2018)
Integrin α6 and EGFR signaling converge at mechanosensitive calpain 2
A. D. Schwartz et al.
BIOMATERIALS (2018)
Epidermal growth factor-mediated Rab25 pathway regulates integrin β1 trafficking in colon cancer
Kyung Sook Hong et al.
CANCER CELL INTERNATIONAL (2018)
Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1/integrin alpha 4 beta 1 system
An-Chen Chang et al.
CANCER LETTERS (2018)
Kindlin-1 Promotes Pulmonary Breast Cancer Metastasis
Sana Sarvi et al.
CANCER RESEARCH (2018)
Continuous Infusion of Cilengitide Plus Chemoradiotherapy for Patients With Stage III Non-Small-cell Lung Cancer: A Phase I Study
Carole Massabeau et al.
CLINICAL LUNG CANCER (2018)
The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network
Xiaochao Tan et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622
William B. Slayton et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling
Jing Luo et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
TGFβ, Fibronectin and Integrin α5β1 Promote Invasion in Basal Cell Carcinoma
Francois Kuonen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [C-11]GSK2256098
Nicholas F. Brown et al.
NEURO-ONCOLOGY (2018)
Rab34 regulates adhesion, migration, and invasion of breast cancer cells
Lixiang Sun et al.
ONCOGENE (2018)
TGF Superfamily Members as Regulators of B Cell Development and FunctionImplications for Autoimmunity
Esther Tamayo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1-Mediated YAP Inhibition
Zhen Sun et al.
CANCER RESEARCH (2018)
Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells
Naoki Takasaka et al.
JCI INSIGHT (2018)
Co-targeting of EGF receptor and neuropilin-1 overcomes cetuximab resistance in pancreatic ductal adenocarcinoma with integrin β1-drivenSrc-Akt bypass signaling
Y-J Kim et al.
ONCOGENE (2017)
CCN2 induces cellular senescence in fibroblasts
Joon-Ii Jun et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2017)
Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer
Christophe Massard et al.
EUROPEAN JOURNAL OF CANCER (2017)
Kruppel-like factor 4 (KLF4): What we currently know
Amr M. Ghaleb et al.
GENE (2017)
Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly
Youmna Attieh et al.
JOURNAL OF CELL BIOLOGY (2017)
Smurf1 inhibits integrin activation by controlling Kindlin-2 ubiquitination and degradation
Xiaofan Wei et al.
JOURNAL OF CELL BIOLOGY (2017)
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
Lynsey M. Whilding et al.
MOLECULAR THERAPY (2017)
EGFR and HER2 activate rigidity sensing only on rigid matrices
Mayur Saxena et al.
NATURE MATERIALS (2017)
Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression
P. A. Guerrero et al.
ONCOGENE (2017)
FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation
H. Zhou et al.
ONCOGENE (2017)
Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1
Y-L Hsu et al.
ONCOGENE (2017)
HOPX hypermethylation promotes metastasis via activating SNAIL transcription in nasopharyngeal carcinoma
Xianyue Ren et al.
NATURE COMMUNICATIONS (2017)
Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells
Stephanie Downs-Canner et al.
NATURE COMMUNICATIONS (2017)
Fibronectin-guided migration of carcinoma collectives
Sandeep Gopal et al.
NATURE COMMUNICATIONS (2017)
Breast cancer metastasis: Putative therapeutic role of vascular cell adhesion molecule-1
Rohit Sharma et al.
CELLULAR ONCOLOGY (2017)
PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression
Philippe Foubert et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial
Jeffrey A. Jones et al.
LANCET HAEMATOLOGY (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells
Justin M. David et al.
ONCOIMMUNOLOGY (2017)
Involvement of the Integrin α1β1 in the Progression of Colorectal Cancer
Salah Boudjadi et al.
CANCERS (2017)
Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3
Nareerat Petpiroon et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
The ILK-MMP9-MRTF axis is crucial for EndMT differentiation of endothelial cells in a tumor microenvironment
Wojciech M. Ciszewski et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
被撤回的出版物: ANGPTL1 Interacts with Integrin α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling (Retracted article. See vol. 82, pg. 4299, 2022)
Qian Yan et al.
CANCER RESEARCH (2017)
Tenascin-C and Integrin α9 Mediate Interactions of Prostate Cancer with the Bone Microenvironment
Rebeca San Martin et al.
CANCER RESEARCH (2017)
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2+ Breast Cancer
Ariella B. Hanker et al.
CANCER RESEARCH (2017)
A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
Tufia Haddad et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1
Yoshikazu Takada et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
Identification of Filamin-A and -B as potential biomarkers for prostate cancer
Niven R. Narain et al.
FUTURE SCIENCE OA (2017)
Integrin α5β1 and p53 convergent pathways in the control of anti-apoptotic proteins PEA-15 and survivin in high-grade glioma
G. Renner et al.
CELL DEATH AND DIFFERENTIATION (2016)
Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer
R. Navab et al.
ONCOGENE (2016)
Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells
S. Boudjadi et al.
ONCOGENE (2016)
A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK)
T. Powles et al.
ANNALS OF ONCOLOGY (2016)
The E3 ubiquitin ligase c-Cbl mediates integrin β1 ubiquitination during dilated cardiomyopathy
Nan Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors
Toshio Shimizu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
RUNX2 promotes breast cancer bone metastasis by increasing integrin α5-mediated colonization
Xiao-Qing Li et al.
CANCER LETTERS (2016)
αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor
Huimin Lu et al.
CANCER RESEARCH (2016)
MFG-E8 Drives Melanoma Growth by Stimulating Mesenchymal Stromal Cell-Induced Angiogenesis and M2 Polarization of Tumor-Associated Macrophages
Kazuya Yamada et al.
CANCER RESEARCH (2016)
Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation
Matthew L. Fisher et al.
CANCER RESEARCH (2016)
α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway
Afshin Varzavand et al.
CANCER RESEARCH (2016)
Regulation of Ligand and Shear Stress-induced Insulin-like Growth Factor 1 (IGF1) Signaling by the Integrin Pathway
Candice G. T. Tahimic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
The kindlin family: functions, signaling properties and implications for human disease
Emanuel Rognoni et al.
JOURNAL OF CELL SCIENCE (2016)
MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling
I. Lakshmanan et al.
ONCOGENE (2016)
Kindlin-2 cooperates with talin to activate integrins and induces cell spreading by directly binding paxillin
Marina Theodosiou et al.
ELIFE (2016)
Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy
Ting Hu et al.
SCIENTIFIC REPORTS (2016)
Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9
Elmina Mammadova-Bach et al.
JCI INSIGHT (2016)
Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)
J. Vansteenkiste et al.
ANNALS OF ONCOLOGY (2015)
Implication of α2β1 integrin in anoikis of MCF-7 human breast carcinoma cells
G. E. Morozevich et al.
BIOCHEMISTRY-MOSCOW (2015)
Integrin αvβ6 sets the stage for colorectal cancer metastasis
D. I. Cantor et al.
CANCER AND METASTASIS REVIEWS (2015)
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling
Eishu Hirata et al.
CANCER CELL (2015)
Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence
Aleksandra Franovic et al.
CANCER RESEARCH (2015)
ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions
Sabrina Schlienger et al.
CELLULAR SIGNALLING (2015)
Integrin αvβ8-Mediated TGF-β Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation
John J. Worthington et al.
IMMUNITY (2015)
Kruppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression
Huan He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Tumour exosome integrins determine organotropic metastasis
Ayuko Hoshino et al.
NATURE (2015)
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa-Silva et al.
NATURE CELL BIOLOGY (2015)
Structural mechanism of integrin inactivation by filamin
Jianmin Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma
Elizabeth R. Gerstner et al.
NEURO-ONCOLOGY (2015)
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
L. Burt Nabors et al.
NEURO-ONCOLOGY (2015)
Alpha2beta1 integrin in cancer development and chemoresistance
Dalila Naci et al.
SEMINARS IN CANCER BIOLOGY (2015)
The ZNF304-integrin axis protects against anoikis in cancer
Burcu Aslan et al.
NATURE COMMUNICATIONS (2015)
Integrin-beta3 clusters recruit clathrin-mediated endocytic machinery in the absence of traction force
Cheng-han Yu et al.
NATURE COMMUNICATIONS (2015)
Structural mechanism of integrin inactivation by filamin
Jianmin Liu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways
Li Yang et al.
ONCOTARGET (2015)
Loss of miR-200b promotes invasion via activating the Kindlin-2/integrin β1/AKT pathway in esophageal squamous cell carcinoma: An E-cadherin-independent mechanism
Hai-Feng Zhang et al.
ONCOTARGET (2015)
Interplay of Endosomal pH and Ligand Occupancy in Integrin α5β1 Ubiquitination, Endocytic Sorting, and Cell Migration
Dmitri Kharitidi et al.
CELL REPORTS (2015)
Photo-thermal effect enhances the efficiency of radiotherapy using Arg-Gly-Asp peptides-conjugated gold nanorods that target αvβ3 in melanoma cancer cells
Ping Li et al.
JOURNAL OF NANOBIOTECHNOLOGY (2015)
Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
E. ELez et al.
ANNALS OF ONCOLOGY (2015)
A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
Hope E. Uronis et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Integrins αvβ3 and αvβ5 as prognostic, diagnostic, and therapeutic targets in gastric cancer
Christine Boeger et al.
GASTRIC CANCER (2015)
Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells
Y. Zhang et al.
ONCOGENE (2015)
MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin
Xiang Zhang et al.
ONCOTARGET (2015)
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)
J. B. Vermorken et al.
ANNALS OF ONCOLOGY (2014)
A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy
Manfred Wirth et al.
EUROPEAN UROLOGY (2014)
Role for the endometrial epithelial protein MFG-E8 and its receptor integrin αvβ3 in human implantation: results of an in vitro trophoblast attachment study using established human cell lines
Carla Schmitz et al.
FERTILITY AND STERILITY (2014)
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin
Jennifer M. Scalici et al.
GYNECOLOGIC ONCOLOGY (2014)
The Transcription Factor IRF8 Activates Integrin-Mediated TGF-β Signaling and Promotes Neuroinflammation
Yuko Yoshida et al.
IMMUNITY (2014)
The fate of internalized α5 integrin is regulated by matrix-capable fibronectin
Henry C. Hsia et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
Kate M. Moore et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition
Laetitia Seguin et al.
NATURE CELL BIOLOGY (2014)
Oncogenic targeting of BRM drives malignancy through C/EBPβ-dependent induction of α5 integrin
L. Damiano et al.
ONCOGENE (2014)
Microenvironmental Stiffness Enhances Glioma Cell Proliferation by Stimulating Epidermal Growth Factor Receptor Signaling
Vaibhavi Umesh et al.
PLOS ONE (2014)
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S. Crystal et al.
SCIENCE (2014)
Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression
Christine Boeger et al.
VIRCHOWS ARCHIV (2014)
Phase Ib safety and pharmacokinetic study of volociximab, an anti-α5β1 integrin antibody, in combination with carboplatin and paclitaxel in advanced non-small-cell lung cancer
B. Besse et al.
ANNALS OF ONCOLOGY (2013)
EGFL7 ligates αvβ3 integrin to enhance vessel formation
Iva Nikolic et al.
BLOOD (2013)
Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization
Afshin Varzavand et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Dasatinib plus Capecitabine for Advanced Breast Cancer: Safety and Efficacy in Phase I Study CA180004
George Somlo et al.
CLINICAL CANCER RESEARCH (2013)
GLI1 regulates a novel neuropilin-2/61 integrin based autocrine pathway that contributes to breast cancer initiation
Hira Lal Goel et al.
EMBO MOLECULAR MEDICINE (2013)
Combination therapy of cilengitide with belotecan against experimental glioblastoma
Young-Hoon Kim et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells
Haobin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
CCM1-ICAP-1 complex controls β1 integrin-dependent endothelial contractility and fibronectin remodeling
Eva Faurobert et al.
JOURNAL OF CELL BIOLOGY (2013)
Integrin inactivators: balancing cellular functions in vitro and in vivo
Daniel Bouvard et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines
Tim Lautenschlaeger et al.
RADIATION ONCOLOGY (2013)
Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
Florence Schaffner et al.
Cancers (2013)
Integrin α1 subunit is up-regulated in colorectal cancer
Salah Boudjadi et al.
BIOMARKER RESEARCH (2013)
Integrin α5β1 Plays a Critical Role in Resistance to Temozolomide by Interfering with the p53 Pathway in High-Grade Glioma
Hana Janouskova et al.
CANCER RESEARCH (2012)
Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization
Benjamin A. Mooso et al.
ENDOCRINE-RELATED CANCER (2012)
Volociximab in cancer
Salah Almokadem et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Involvement of the TGFβ pathway in the regulation of α5β1 integrins by caveolin-1 in human glioblastoma
Erika C. Cosset et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
A phase I study of continuous infusion cilengitide in patients with solid tumors
Peter H. O'Donnell et al.
INVESTIGATIONAL NEW DRUGS (2012)
α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)
Dalila Naci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion
Yasuhito Onodera et al.
JOURNAL OF CELL BIOLOGY (2012)
Cdc42 promotes transendothelial migration of cancer cells through β1 integrin
Nicolas Reymond et al.
JOURNAL OF CELL BIOLOGY (2012)
β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy
Iris Eke et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Fabienne Danhier et al.
MOLECULAR PHARMACEUTICS (2012)
MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits
Hong Liu et al.
NATURE CELL BIOLOGY (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma
Kevin B. Kim et al.
MELANOMA RESEARCH (2012)
CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling
P-K Lo et al.
ONCOGENE (2012)
A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
M. N. Fornier et al.
ANNALS OF ONCOLOGY (2011)
A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
S. O'Day et al.
BRITISH JOURNAL OF CANCER (2011)
Receptor Tyrosine Kinases and TLR/IL1 Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
Michael C. Schmid et al.
CANCER CELL (2011)
The Integrin αvβ3-5 Ligand MFG-E8 Is a p63/p73 Target Gene in Triple-Negative Breast Cancers but Exhibits Suppressive Functions in ER+ and erbB2+ Breast Cancers
Chuanwei Yang et al.
CANCER RESEARCH (2011)
Integrin α3β1 as a breast cancer target
Sita Subbaram et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
Katherine M. Bell-McGuinn et al.
GYNECOLOGIC ONCOLOGY (2011)
Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces
Claudia Tanja Mierke et al.
JOURNAL OF CELL SCIENCE (2011)
SHARPIN is an endogenous inhibitor of β1-integrin activation
Juha K. Rantala et al.
NATURE CELL BIOLOGY (2011)
Cilengitide induces autophagy-mediated cell death in glioma cells
Stephanie L. Lomonaco et al.
NEURO-ONCOLOGY (2011)
β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells
V. Morello et al.
ONCOGENE (2011)
Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer
Roya Navab et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
beta 1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib
Catherine Huang et al.
BREAST CANCER RESEARCH (2011)
α5β1-Integrin Expression Is Essential for Tumor Progression in Experimental Lung Cancer
Jesse Roman et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
Maike Buchner et al.
BLOOD (2010)
A Randomized Phase 2 Study of Etaracizumab, a Monoclonal Antibody Against Integrin αvβ3, ± Dacarbazine in Patients With Stage IV Metastatic Melanoma
Peter Hersey et al.
CANCER (2010)
Combined anti-angiogenic therapy against VEGF and integrin alphabeta in an orthotopic model of ovarian cancer
Tae Jin Kim et al.
CANCER BIOLOGY & THERAPY (2010)
Anti-αv Integrin Monoclonal Antibody Intetumumab Enhances the Efficacy of Radiation Therapy and Reduces Metastasis of Human Cancer Xenografts in Nude Rats
Shoucheng Ning et al.
CANCER RESEARCH (2010)
Integrin Alpha 6 Regulates Glioblastoma Stem Cells
Justin D. Lathia et al.
CELL STEM CELL (2010)
The Laminin Binding Integrin α6β1 in Prostate Cancer Perineural Invasion
Isis C. Sroka et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Integrin-mediated function of Rab GTPases in cancer progression
Dhatchayini Subramani et al.
MOLECULAR CANCER (2010)
RGD-Conjugated Dendrimer-Modified Gold Nanorods for in Vivo Tumor Targeting and Photothermal Therapy
Zhiming Li et al.
MOLECULAR PHARMACEUTICS (2010)
The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing
Joon-Il Jun et al.
NATURE CELL BIOLOGY (2010)
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Gwendal Lazennec et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Negative Regulation of β4 Integrin Transcription by Homeodomain-Interacting Protein Kinase 2 and p53 Impairs Tumor Progression
Giulia Bon et al.
CANCER RESEARCH (2009)
The reverse Warburg effect Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Stephanos Pavlides et al.
CELL CYCLE (2009)
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency
Tom Mikkelsen et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of β1-integrin
Dominique T. Brandt et al.
NATURE CELL BIOLOGY (2009)
Integrins: masters and slaves of endocytic transport
Patrick T. Caswell et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: Implications for antiangiogenic drugs as chemosensitizing agents
Yuval Shaked et al.
CANCER CELL (2008)
Loss of integrin α1β1 ameliorates Kras-induced lung cancer
Ines Macias-Perez et al.
CANCER RESEARCH (2008)
β1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts
Catherine C. Park et al.
CANCER RESEARCH (2008)
Volociximab, a Chimeric Monoclonal Antibody that Specifically Binds α5β1 Integrin: A Phase I, Pharmacokinetic, and Biological Correlative Study
Alejandro D. Ricart et al.
CLINICAL CANCER RESEARCH (2008)
Angiostatic activity of obtustatin as α1β1 integrin inhibitor in experimental melanoma growth
Meghan C. Brown et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cell adaptive response to extracellular matrix density is controlled by ICAP-1-dependent β1-integrin affinity
Angelique Millon-Fremillon et al.
JOURNAL OF CELL BIOLOGY (2008)
Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric brain tumor consortium study PBTC-012
Tobey J. MacDonald et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
David A. Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway
Leticia Oliveira-Ferrer et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
TGF-β inhibits IL-2 production and promotes cell cycle arrest in TCR-activated effector/memory T cells in the presence of sustained TCR signal transduction
Lopamudra Das et al.
JOURNAL OF IMMUNOLOGY (2008)
Structural basis for the interaction between the cytoplasmic domain of the hyaluronate receptor layilin and the talin F3 subdomain
Kate L. Wegener et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function
Liang Zhou et al.
NATURE (2008)
The regulatory RAB and ARF GTPases for vesicular trafficking
Erik Nielsen et al.
PLANT PHYSIOLOGY (2008)
Tumor-Selective Response to Antibody-Mediated Targeting of αvβ3 Integrin in Ovarian Cancer
Charles N. Landen et al.
NEOPLASIA (2008)
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Yukiko Tone et al.
NATURE IMMUNOLOGY (2008)
Phase I and pharmacokinetic study of etaracizumab (Abegrin™), a humanized monoclonal antibody against αvβ3 integrin receptor, in patients with advanced solid tumors
Catherine Delbaldo et al.
INVESTIGATIONAL NEW DRUGS (2008)
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer
David R. Clemmons
NATURE REVIEWS DRUG DISCOVERY (2007)
Rab25 associates with α5β1 integrin to promote invasive migration in 3D microenvironments
Patrick T. Caswell et al.
DEVELOPMENTAL CELL (2007)
Integrin modulation and signaling in leukocyte adhesion and migration
David M. Rose et al.
IMMUNOLOGICAL REVIEWS (2007)
Fibrinogen inhibits neurite outgrowth via β3 integrin-mediated phosphorylation of the EGF receptor
Christian Schachtrup et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Integrin all regulates IGF2 expression in fibroblasts to enhance tumorigenicity of human non-small-cell lung cancer cells
Chang-Qi Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival
S. Hazelbag et al.
JOURNAL OF PATHOLOGY (2007)
A peptide selected by biopanning identifies the integrin αvβ6 as a prognostic biomarker for nonsmall cell lung cancer
Anissa N. Elayadi et al.
CANCER RESEARCH (2007)
Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin β6
Janeen Azare et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Determination of the ligand-binding specificities of the α2β1 and α1β1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer
John J. Grzesiak et al.
PANCREAS (2007)
The integrins
Yoshikazu Takada et al.
GENOME BIOLOGY (2007)
Cooperation between Myc and YY1 provides novel silencing transcriptional targets of alpha 3 beta 1-integrin in tumour cells
F. de Nigris et al.
ONCOGENE (2007)
The Rab4A effector protein Rabip4 is involved in migration of NIH 3T3 fibroblasts
Jelena Vukmirica et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis
Wenjun Guo et al.
CELL (2006)
Blocking the α4 integrin-paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site
CC Féral et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The molecular basis of filamin binding to integrins and competition with talin
T Kiema et al.
MOLECULAR CELL (2006)
Increased expression of integrin αvβ5 induces the myofibroblastic differentiation of dermal fibroblasts
Y Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Integrin trafficking and the control of cell migration
PT Caswell et al.
TRAFFIC (2006)
Biological and molecular properties of a new αvβ3/αvβ5 integrin antagonist
L Belvisi et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Upregulation of a functional form of the β4 integrin subunit in colorectal cancers correlates with c-Myc expression
HH Ni et al.
ONCOGENE (2005)
Cbl-mediated ubiquitination of α5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation
K Kaabeche et al.
JOURNAL OF CELL SCIENCE (2005)
Focal adhesion kinase: In command and control of cell motility
SK Mitra et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation
LH Parker et al.
NATURE (2004)
Modulation of prostate cancer growth in bone microenvironments
M Edlund et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Integrins: dynamic scaffolds for adhesion and signaling in platelets
SJ Shattil et al.
BLOOD (2004)
CNTO 95, a fully human monoclonal antibody that inhibits αv integrins, has antitumor and antiangiogenic activity in vivo
M Trikha et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Roles of αv integrins in vascular biology and pulmonary pathology
D Sheppard
CURRENT OPINION IN CELL BIOLOGY (2004)
VE-statin, an endothelial repressor of smooth muscle cell migration
F Soncin et al.
EMBO JOURNAL (2003)
N-Myc overexpression leads to decreased β1 integrin expression and increased apoptosis in human neuroblastoma cells
CM van Golen et al.
ONCOGENE (2003)
Disruption of focal adhesions by integrin cytoplasmic domain-associated protein-1α
D Bouvard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Type Iγ phosphatidylinositol phosphate kinase targets and regulates focal adhesions
K Ling et al.
NATURE (2002)
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease
MF Neurath et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Different phenotypes in human prostate cancer:: α6 or α3 integrin in cell-extracellular adhesion sites
M Schmelz et al.
NEOPLASIA (2002)
The integrin αvβ8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-β1
DZ Mu et al.
JOURNAL OF CELL BIOLOGY (2002)
Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells
G Schratt et al.
JOURNAL OF CELL BIOLOGY (2002)
Integrins and prostate cancer metastases
M Fornaro et al.
CANCER AND METASTASIS REVIEWS (2001)
Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells
F Aoudjit et al.
ONCOGENE (2001)
Cutting edge:: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression
L Gorelik et al.
JOURNAL OF IMMUNOLOGY (2000)
Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin
S Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Mechanisms of angiogenesis and arteriogenesis
P Carmeliet
NATURE MEDICINE (2000)
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma
Kyaw L. Aung et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY